EW vs LWACW · P/E 47, rev $3.39B vs $217.7M cap
Edwards Lifesciences Corp (EW) versus LightWave Acquisition Corp. Warrants (LWACW) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
LightWave Acquisition Corp. Warrants (LWACW) common stock listed on NASDAQ.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
LWACW does not have a complete income-statement cache yet.
EW currently screens at market cap $49.91B and trailing P/E 46.9. LWACW currently screens at market cap $217.7M.
Not investment advice. Open the EW and LWACW stock pages for the full models.
Not investment advice.